Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22525883 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Mucosal Healing Study in Crohn's Disease (CD)
Condition: Crohn's Disease
Intervention: Biological: Certolizumab pegol

Indicates status has not been verified in more than two years